Inventor · disambiguated record
Duncan Walker
Also filed as: WALKER DUNCAN · WALKER DUNCAN HERRICK
12 granted patents·3 pending applications·343 citations·filing 1998–2024
91Inventor score
Top patents by PatentIndex Score
15 records- 0197US6369086B1Substituted oxidole derivatives as protein tyrosine and as protein serine/threonine kinase inhibitorsSMITHKLINE BEECHAM CORP·Filed 1999·Granted Apr 9, 2002·213 cites·18 claims
- 0295US11497743B2Treating patients harboring an isocitrate dehydrogenase 1 (IDH-1) mutationFORMA THERAPEUTICS INC·Filed 2020·Granted Nov 15, 2022·3 cites·22 claims
- 0395US7105529B2Substituted oxindole derivatives as protein tyrosine and as protein serine/threonine kinase inhibitors and compositions and methods of treating chemotherapy and radiation therapy side effectsSMITHKLINE BEECHAM CORP·Filed 2001·Granted Sep 12, 2006·64 cites·5 claims
- 0491US11963956B2Inhibiting mutant isocitrate dehydrogenase 1 (mIDH-1)FORMA THERAPEUTICS INC·Filed 2022·Granted Apr 23, 2024·1 cites·20 claims
- 0588US11738018B2Inhibiting mutant isocitrate dehydrogenase 1 (mIDH-1)FORMA THERAPEUTICS INC·Filed 2021·Granted Aug 29, 2023·1 cites·20 claims
- 0687US6541503B2Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitorsSMITHKLINE BEECHAM CORP·Filed 2001·Granted Apr 1, 2003·22 cites·17 claims
- 0784US11311527B2Inhibiting mutant isocitrate dehydrogenase 1 (mIDH-1)FORMA THERAPEUTICS INC·Filed 2020·Granted Apr 26, 2022·1 cites·19 claims
- 0884US11013734B2Treating patients harboring an isocitrate dehydrogenase-1 (IDH-1) mutationFORMA THERAPEUTICS INC·Filed 2019·Granted May 25, 2021·1 cites·24 claims
- 0982US11576906B2Inhibiting mutant IDH-1FORMA THERAPEUTICS INC·Filed 2019·Granted Feb 14, 2023·1 cites·3 claims
- 1080US2024148718A1INHIBITING MUTANT ISOCITRATE DEHYDROGENASE 1 (mIDH-1)FORMA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1178US11013733B2Inhibiting mutant isocitrate dehydrogenase 1 (mlDH-1)FORMA THERAPEUTICS INC·Filed 2019·Granted May 25, 2021·1 cites·21 claims
- 1278US6387919B1Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitorsGLAXO WELLCOME INC·Filed 1998·Granted May 14, 2002·34 cites·13 claims
- 1377US2025082628A1INHIBITING MUTANT ISOCITRATE DEHYDROGENASE 1 (mIDH-1)FORMA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1476US11376246B2Inhibiting mutant IDH-1FORMA THERAPEUTICS INC·Filed 2019·Granted Jul 5, 2022·1 cites·10 claims
- 1561US2023101121A1Treating patients harboring an isocitrate dehydrogenase-1 (idh-1) mutationFORMA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Duncan Walker files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →